The SSGCID includes the following research organizations: Seattle Children's Research Institute, University of Kansas, UCB, the University of Washington, and Washington State University.
This partnership represents a unique blending of academic, institutional, and industrial efforts with a history of producing technological advances and innovations, expertise in infectious diseases and drug development, and proven ability to work with challenging protein targets, employing state-of-the-art structural genomic research.
Click on the logos below for more information about each site.
SSGCID is working closely with the other NIAID-funded center (CSGID).
What a special moment: the #COVID19 vaccine we designed with @coronalexington @KingLabIPD has met its primary endpo… https://t.co/ibOyhUL2IU
3 months, 3 weeks ago
@ResearchAtKU @UnivOfKansas @NIAIDNews @KUnews @KUPharmacy @KUMolBio So glad to have the Lovell Lab @UnivOfKansas… https://t.co/6VjHdx6ELe
8 months, 2 weeks ago
@M0US3Y007 Great collaborative work with @M0US3Y007 , looking forward to continuing the partnership with… https://t.co/ZZv2l8CjSL
9 months, 1 week ago